Alternatively, the NRF2 transcription factor serves as a pivotal regulator of the endogenous antioxidant defense [57] and the activation of its downstream target genes, such as HO-1, SOD-1, and GSTM1, is crucial for regulating neuropathy induced by chemotherapy [58]. This evidence concerns the gene GSTM1 and neuropathy.